These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1139740)

  • 41. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation.
    Ramsdell HS; Eaton DL
    Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of butylated hydroxytoluene pretreatment on the metabolism and genotoxicity of aflatoxin B1 in primary cultures of adult rat hepatocytes: selective reduction of nucleic acid binding.
    Salocks CB; Hsieh DP; Byard JL
    Toxicol Appl Pharmacol; 1984 Dec; 76(3):498-509. PubMed ID: 6209823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of aflatoxin B1 binding to hepatic DNA by dehydroepiandrosterone in vivo.
    Prasanna HR; Lu MH; Beland FA; Hart RW
    Carcinogenesis; 1989 Dec; 10(12):2197-200. PubMed ID: 2531635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemopreventive properties of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and anti-mutagenic activity against AFB1 and two heterocyclic amines in the Salmonella mutagenicity assay.
    Dashwood RH; Breinholt V; Bailey GS
    Carcinogenesis; 1991 May; 12(5):939-42. PubMed ID: 1903094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mapping the binding site of aflatoxin B1 in DNA: molecular modeling of the binding sites for the N(7)-guanine adduct of aflatoxin B1 in different DNA sequences.
    Loechler EL; Teeter MM; Whitlow MD
    J Biomol Struct Dyn; 1988 Jun; 5(6):1237-57. PubMed ID: 3152159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative and qualitative characterization of aflatoxin B1 adducts formed in vivo within the ribosomal RNA genes of rat liver DNA.
    Irvin TR; Wogan GN
    Cancer Res; 1985 Aug; 45(8):3497-502. PubMed ID: 3926300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse.
    Monroe DH; Eaton DL
    Toxicol Appl Pharmacol; 1987 Sep; 90(3):401-9. PubMed ID: 3116723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of rats.
    Lotlikar PD; Raj HG; Bohm LS; Ho LL; Jhee EC; Tsuji K; Gopalan P
    Cancer Res; 1989 Feb; 49(4):951-7. PubMed ID: 2492210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative carcinogenesis and dosimetry in rainbow trout for aflatoxin B1 and aflatoxicol, two aflatoxins that form the same DNA adduct.
    Bailey GS; Loveland PM; Pereira C; Pierce D; Hendricks JD; Groopman JD
    Mutat Res; 1994 Aug; 313(1):25-38. PubMed ID: 7519308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation studies between the binding of aflatoxin B1 to chromatin components and the inhibition of RNA synthesis.
    Yu FL; Geronimo IH; Bender W; Permthamsin J
    Carcinogenesis; 1988 Apr; 9(4):527-32. PubMed ID: 3128406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carcinogen-nucleic acid interactions: equilibrium binding studies of aflatoxins B1 and B2 with DNA and the oligodeoxynucleotide d(ATGCAT)2.
    Stone MP; Gopalakrishnan S; Harris TM; Graves DE
    J Biomol Struct Dyn; 1988 Apr; 5(5):1025-41. PubMed ID: 3152158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione.
    Kensler TW; Egner PA; Trush MA; Bueding E; Groopman JD
    Carcinogenesis; 1985 May; 6(5):759-63. PubMed ID: 3924431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of low level of dietary protein and estrogen administration on the aflatoxin-protein complexes in rat liver cytosol.
    Mainigi KD
    Toxicol Lett; 1982 Nov; 14(1-2):57-62. PubMed ID: 7157416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative effect of dietary butylated hydroxyanisole and beta-naphthoflavone on aflatoxin B1 metabolism, DNA adduct formation, and carcinogenesis in rainbow trout.
    Goeger DE; Shelton DW; Hendricks JD; Pereira C; Bailey GS
    Carcinogenesis; 1988 Oct; 9(10):1793-800. PubMed ID: 3139317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of ethanol on the in vivo covalent binding and in vitro metabolism of aflatoxin B1 in rats.
    Toskulkao C; Glinsukon T
    Toxicol Lett; 1986 Feb; 30(2):151-7. PubMed ID: 2422790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding of [14C] azaserine to DNA and protein in the rat and hamster.
    Zurlo J; Coon CI; Longnecker DS; Curphey TJ
    Cancer Lett; 1982; 16(1):65-70. PubMed ID: 7116340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of diet and route of administration on the DNA binding of aflatoxin B1 in the rat.
    Salbe AD; Bjeldanes LF
    Carcinogenesis; 1989 Apr; 10(4):629-34. PubMed ID: 2702710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat.
    Mandel HG; Manson MM; Judah DJ; Simpson JL; Green JA; Forrester LM; Wolf CR; Neal GE
    Cancer Res; 1987 Oct; 47(19):5218-23. PubMed ID: 2887284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation and deactivation of aflatoxin B1 in isolated rat hepatocytes.
    Ch'ih JJ; Lin T; Devlin TM
    Biochem Biophys Res Commun; 1983 Jan; 110(2):668-74. PubMed ID: 6404260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.